Maintenance and Transmission of Rift Valley Fever Virus and Other Emerging Infectious Diseases in East and Central Africa

Status: Recruiting
Location: See all (10) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

Rift Valley fever (RVF), a disease transmitted from livestock (cattle, sheep, goats, camels) to humans more commonly occurs in the East and Central Africa (ECA) regions where more than 15 major epidemics affecting more than one country have been reported over the past 50 years. Within the region, there are specific areas, referred to as hotspots, which support RVF virus maintenance via low-level virus circulation between animals, humans, and mosquitoes. Most outbreaks originate from these hotspots. Our goal is to conduct studies in RVF hotspots in four ECA countries, Kenya, Uganda, Tanzania, and Democratic Republic of Congo (DRC) to determine the burden of RVF disease among humans, wildlife and livestock during inter-epidemic periods (IEPs) and discover circulation of undetected infectious diseases. This information is important for use in developing an early warning system and possibly a vaccination strategy. The study will take place in Uganda, Kenya, Tanzania and Democratic Republic of Congo

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Healthy Volunteers: t
View:

• Category A: A sample of patients presenting to the health facility meeting this inclusion criteria will be enrolled:

• • Persons ≥ 10 years of age who are malaria negative AND have undifferentiated acute fever at the time of presentation (≥ 37.5°C) or reported fever in the past 4 weeks.

• Category B: A sample of patients presenting to the health facility meeting this inclusion criteria will be enrolled:

• • Persons ≥ 10 years of age who are malaria positive AND have undifferentiated acute fever at the time of presentation (≥ 37.5°C) or reported fever in the past 4 weeks.

• Category C: All patients at the health facility meeting these criteria will be enrolled in the study

• Persons ≥ 10 years of age with:

• • Unexplained bleeding with or without fever manifesting as either: Blood in vomitus, Bleeding from the gums, Bleeding from the nose, Bleeding in the eyes (red eyes), Non-menstrual genital bleeding, Bleeding from any other body site OR

• • Infectious disease illness of unknown etiology requiring hospitalization. The illness should not be responding to antimalarials and/or antibiotics following 7 days of treatment

• Member of household 2 or more years of age.

Locations
Other Locations
Democratic Republic of the Congo
South Kivu
NOT_YET_RECRUITING
Bukavu
Virunga Hospital & North Kivu
RECRUITING
Goma
Kenya
Tana River County
NOT_YET_RECRUITING
Hola
Isiolo county
NOT_YET_RECRUITING
Isiolo
Marsabit county
NOT_YET_RECRUITING
Marsabit
Muranga county
NOT_YET_RECRUITING
Murang’a
Uganda
Rwekubbo health centre IV & Isingiro district
RECRUITING
Isingiro
Kabale Regional Referral Hospital & Kabale district
RECRUITING
Kabale
Rwekubo Health Centre IV & Rubanda district
RECRUITING
Rubanda
United Republic of Tanzania
Iringa
NOT_YET_RECRUITING
Iringa
Contact Information
Primary
Jeanette A Dawa, PhD
jeanette.dawa@wsu.edu
+254750653696
Backup
M. Kariuki Njenga, PhD
mkariuki.njenga@wsu.edu
+254700354441
Time Frame
Start Date: 2021-10-08
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 5000
Treatments
Health facility based cohort
Cohort of individuals with acute or reported fever enrolled at health facilities and followed up for upto 24 months.
Community survey
Individuals enrolled in study as part of a cross sectional survey in the community.
Sponsors
Collaborators: Washington University School of Medicine, Ministry of Agriculture, Animal Industry and Fisheries, Uganda, Emory University, Ministry of Agriculture, Fisheries and Livestock, Democratic Republic of Congo, The International Livestock Research Institute (ILRI), Charite University, Berlin, Germany, Kenya Medical Research Institute, Ministry of Agriculture Livestock Fisheries and Cooperatives, Kenya, Sokoine University of Agriculture, Kenya Ministry of Health, National Institute of Allergy and Infectious Diseases (NIAID), Ministry of Public Health, Democratic Republic of the Congo, Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo, Ministry of Health, Uganda, Institute of Tropical Medicine, Belgium, MRC/UVRI and LSHTM Uganda Research Unit, University of Nairobi
Leads: Washington State University

This content was sourced from clinicaltrials.gov